Larvol Delta - Mateon-Therapeutics-Team-Publishes-Three-New-PeerReviewed-Oncology-Articles-Outlining-the-Clinical-Impact-Potential-of-Its-FirstInClass-AntiTGFBeta-RNA-Therapeutic-OT101Trabedersen

trabedersen (OT-101) - Autotelic, Mateon Therapeutics

http://www.globenewswire.com/news-release/2019/12/02/1954842/0/en/Mateon-Therapeutics-Team-Publishes-Three-New-Peer-Reviewed-Oncology-Articles-Outlining-the-Clinical-Impact-Potential-of-Its-First-In-Class-Anti-TGF-Beta-RNA-Therapeutic-OT101-Trabe.html

Dec 2, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next